Summaries of the Section H (HML) update

Each month we issue a summary of the HML update. The table on this page gives a preview of the upcoming changes.

The table on this page gives a preview of the upcoming changes that will be announced in next month’s Section H of the Pharmaceutical Schedule.

The changes will be published in the Online HML(external link) around the 23^rd of this month and are effective from next month.

For any questions about these listing changes or the Pharmaceutical Schedule in general, email us at enquiry@pharmac.govt.nz.

18 May 2026 - preview of changes for June 2026

Pharmaceutical	Change
Beta-HCG low sensitivity urine test kit (CheckTop) midstream	price increase
Colestyramine (Questran Light (Neon)) powder for oral suspension 4 g sachet	new listing (p’code 2700026)
Cyclizine lactate (Hameln) inj 50 mg per ml, 1 ml ampoule	price increase
Doxorubicin hydrochloride (Adriamycin) inj 2 mg per ml, 100 ml vial	new listing (p’code 2730138)
Droperidol (Droperidol Panpharma) inj 2.5 mg per ml, 1 ml ampoule	new listing (p’code 2527138)
Efavirenz with emtricitabine and tenofovir disoproxil (TEEVIR (India)) tab 600 mg with emtricitabine 200 mg and tenofovir disoproxil 245 mg (300 mg as a fumarate)	new listing (p’code 2727994)
Elexacaftor with tezacaftor, ivacaftor and ivacaftor (Trikafta) Tab elexacaftor 50 mg with tezacaftor 25 mg, ivacaftor 37.5 mg (56) and ivacaftor 75 mg (28) Tab elexacaftor 100 mg with tezacaftor 50 mg, ivacaftor 75 mg (56) and ivacaftor 150 mg (28) Oral granules elexacaftor 80 mg with tezacaftor 40 mg, ivacaftor 60 mg (28) and ivacaftor 59.5mg (28), sachets Oral granules elexacaftor 100 mg with tezacaftor 50 mg, ivacaftor 75 mg (28) and ivacaftor 75 mg (28), sachets	amended restriction criteria
Ezetimibe with simvastatin (Vytorin) tab 10 mg with simvastatin 80 mg	new listing (p’code 2727730)
Glucose [Dextrose] (HypoPak Glucose) oral soln 15 g per 80 ml sachet	price increase
Ivacaftor (Kalydeco) tab 150 mg and oral granules 13.4 mg, 25 mg, 50 mg and 75 mg, sachet	amended restriction criteria
Montelukast (Montelukast Paediatric (Relonchem)) tab 5 mg	amended brand name
Nimodipine (Nimorhage) tab 30 mg	new listing (p’code 2729865)
Oestradiol valerate (Progynova) tab 2 mg	new listing (p’code 2730979)
Paracetamol oral liq 120 mg per 5 ml, 200 ml	Brand change Noumed – new listing and addition of PSS (p’code 2721376) Paracetamol (Ethics) to be delisted 1 November 2026
Progesterone (Utrogestan) cap 100 mg	new listing (p’code 2730340)
Ramipril (Ramipril Viatris) tab 2.5 mg	new listing (p’code 2728184)
Ribociclib (Kisqali) tab 200 mg	new listing 21 tab pack (p’code 2728133) 42 tab pack (p’code 2728141) 63 tab pack (p’code 2728168)
Risperidone (Risperidone Sandoz)	new listing tab 0.5 mg (p’code 2693143) tab 2 mg (p’code 2693178)
Rizatriptan (Rizatriptan Viatris) tab orodispersible 10 mg	new listing (p’code 2728311)
Rotavirus oral vaccine (Rotarix) oral susp live attenuated human rotavirus 1,000,000 CCID50 per dose, squeezable tube	delisted 1 June 2026
Sodium bicarbonate (Sodibic) cap 840 mg	Pharmacode 2085992 delisted 1 June 2026
Trimethoprim with sulphamethoxazole [Co-trimoxazole] (Deprim) oral liq 8 mg sulphamethoxazole 40 mg per ml, 100 ml	new listing (p’code 2730847)
Vanzacaftor with tezacaftor and deutivacaftor (Alyftrek) tab vanzacaftor 4 mg with tezacaftor 20 mg and deutivacaftor 50 mg and tab vanzacaftor 10 mg with tezacaftor 50 mg and deutivacaftor 125 mg	amended restriction criteria
Venetoclax (Venclexta) tab 14 × 10 mg, 7 × 50 mg, 21 × 100 mg, tab 10 mg, tab 50 mg and tab 100 mg	amended restriction criteria
Water (Multichem) inj 10 ml ampoule	price increase and addition of PSS
Water (Fresenius Kabi) inj 10 ml ampoule	delisted 1 June 2026

Find previous months' summaries